Tower Research Capital (TRC)’s 2ndVote Life Neutral Plus ETF LYFE Stock Holding History
Bought
Maintained
Sold
Other funds holding LYFE
BTI
SFG
HI
WP
Tower Research Capital (TRC)'s LYFE Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of 2ndVote Life Neutral Plus ETF (LYFE) in Q1 2023, closing a stake of 10,520 shares — an estimated $305K sold.
Tower Research Capital (TRC) first reported a position in LYFE in Q4 2020 and held it in 7 quarters. The position peaked at $1.38M in Q1 2022. 11 funds tracked by Wall St. Rank hold LYFE as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining 2ndVote Life Neutral Plus ETF position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 10,520 2ndVote Life Neutral Plus ETF shares in Q1 2023, an estimated $305K.
- Tower Research Capital (TRC) first reported a position in 2ndVote Life Neutral Plus ETF in Q4 2020 and held it in 7 quarters.
- Tower Research Capital (TRC)'s 2ndVote Life Neutral Plus ETF position peaked at $1.38M in Q1 2022.
- 11 funds tracked by Wall St. Rank held 2ndVote Life Neutral Plus ETF as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.